INFI
Infinity Pharmaceuticals, Inc.
INFI
INFI
Delisted
INFI was delisted on the 13th of September, 2023.
66 hedge funds and large institutions have $59.6M invested in Infinity Pharmaceuticals, Inc. in 2018 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 17 increasing their positions, 15 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
2% more funds holding
Funds holding: 65 → 66 (+1)
Holders
66
Holding in Top 10
–
Calls
$287K
Puts
$126K
Top Buyers
| 1 | +$3.67M | |
| 2 | +$1.92M | |
| 3 | +$747K | |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
+$667K |
| 5 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$606K |
Top Sellers
| 1 | -$1.83M | |
| 2 | -$824K | |
| 3 | -$445K | |
| 4 |
Renaissance Technologies
New York
|
-$316K |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$306K |